Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-03-26
1999-11-02
Ford, John M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544262, A61K 31505, C07D48704
Patent
active
059771186
ABSTRACT:
6-Substituted pyrazolo[3,4-d]pyrimidin-4-one derivatives, pharmaceutical compositions containing them and methods for effecting c-GMP-phosphodiesterase inhibition and for treating heart failure and/or hypertension.
REFERENCES:
patent: 3211731 (1965-10-01), Schmidt et al.
patent: 3716555 (1973-02-01), Howarth et al.
patent: 3821282 (1974-06-01), Hoyle et al.
Silver et al. "Cyclic GMP Potentiation by WIN 58237, a Novel Cyclic Nucleotide . . . " J. Pharm. Exp. Ther. 271, 1143-1148 (1994).
Bacon Edward R.
Daum Sol J.
Singh Baldev
Alexander Michael D.
DuPont Paul E.
Ford John M.
Sanofi
LandOfFree
6-substituted pyrazolo[3,4-d]pyrimidin-4-ones and compositions a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 6-substituted pyrazolo[3,4-d]pyrimidin-4-ones and compositions a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 6-substituted pyrazolo[3,4-d]pyrimidin-4-ones and compositions a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2135771